Tag: VIVA 2025
“Excellent” one-year outcomes from ROADSTER 3 show TCAR is “safe and...
One-year outcomes in the ROADSTER 3 post-approval study evaluating the safety and effectiveness of transcarotid artery revascularisation (TCAR) using the Enroute stent and neuroprotection...
PERFORMANCE III demonstrates “very low” 30-day event rates for dual neuroprotection...
Thirty-day results from the PERFORMANCE III study of integrated embolic protection (IEP) in transcarotid artery revascularisation (TCAR) have demonstrated "very low" 30-day event rates....
